Cyclopentasiloxane (D5) and Cyclotetrasiloxane (D4), two of the most common silicones used in cosmetic products, were recently restricted for use in the European Union.
Beauty and personal care
SCCS final opinion on UV filter S87 and hair dye C183
Introducing cosmetic products, requirements for cosmetic products on eu market, obligations for cosmetic products on eu market, Compliance process
AEMPS: Quarterly report of the Spanish Authorities about cosmetic products – July to September 2019
The Spanish Authorities have published their quarterly report about cosmetic products vigilance and control and some points are to be highlighted.
Read more about it.
SCCS releases a final opinion on Allergy Alert Test (AAT)
Introducing cosmetic products to European market, requirements for cosmetic products on eu market, European responsible person cosmetics
Revision of 2 restrictions under the EU Cosmetics Regulation (HEPB, TiO2[nano])
Requirements for cosmetic products on eu market, cosmetics compliance process eu market, obligations for cosmetics manufacturers Europe
Several important opinions issued by the SCCS
The Scientific Committee on Consumer Safety (SCCS) recently scrutinized several ingredients, commonly used in various cosmetics products.
Why is label review one of the last steps in the compliance process?
Answering questions on the cosmetics products labelling process. When should you label your product? Find out with Obelis' EU regulatory consulting team.
Spain is ready for Brexit: new checklist for Medical Devices and Cosmetics
The Spanish Agency of Medicines and Medical Devices (AEMPS) has published a Checklist to verify the Brexit readiness of companies based in Spain in the sectors…
OEM with European ambition?
Having a commercial brand is not necessary, even as an OEM you can register your products in the CPNP and enjoy the benefits.
Cosmeto-vigilance what to do?
Every cosmetic manufacturer, sooner or later, will be faced with a cosmeto-vigilance case. If there are sales, the undesirable effects will happen. It is therefore crucial to react to every case in an appropriate manner and for the Serious Undesirable Effects (SUE) to inform the relevant authorities – which is a legal obligation.